Publications in collaboration with researchers from Instituto de Investigación Biomédica de Salamanca (24)

2025

  1. Corrigendum to “Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review” [Clin. Translat. Radiat. Oncol. 52 (2025) 100930](S2405630825000205)(10.1016/j.ctro.2025.100930)

    Clinical and Translational Radiation Oncology

  2. Current and future perspectives in clinical practice in KRAS-mutated non-small cell lung cancer: a literature review

    Precision Cancer Medicine, Vol. 7, pp. 1-13

  3. Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review

    Clinical and Translational Radiation Oncology, Vol. 52

  4. Neoadjuvant chemoimmunotherapy or chemoradiotherapy in stage III non-small cell lung cancer: crossing the Rubicon?

    Chinese Clinical Oncology, Vol. 14, Núm. 5

  5. Prognostic impact of negative TTF-1 biomarker in metastatic lung adenocarcinoma treated with chemo-immunotherapy: a retrospective cohort study

    Translational Lung Cancer Research, Vol. 14, Núm. 7, pp. 2494-2508

2024

  1. Acute pulmonary embolism masking a pulmonary artery sarcoma

    Medicina Clinica

  2. Cancer-Associated Thrombotic Microangiopathy: Literature Review and Report of Five Cases

    Life, Vol. 14, Núm. 7

  3. Current and future perspectives in clinical practice in KRAS-mutated non-small cell lung cancer: a literature review

    Precision Cancer Medicine, pp. 1-13

  4. Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review

    Chinese Clinical Oncology, Vol. 13, Núm. 3

  5. Response to platinum-based therapies in second-line after immunotherapy in advanced or metastatic non-small-cell lung cancer PD-L1 ≥50%

    Translational Lung Cancer Research, Vol. 13, Núm. 10, pp. 2649-2659

2023

  1. Biomarkers for immunotherapy in non-small cell lung cancer: a current and future reality

    Precision Cancer Medicine

  2. Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data

    Cancers, Vol. 15, Núm. 17

  3. Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis

    Chinese Clinical Oncology, Vol. 12, Núm. 6

  4. Reply to «Considerations to the manuscript cancer and elderly: Two incompatible concepts for intensive care?»

    Revista Espanola de Geriatria y Gerontologia

  5. Uso de anakinra en el tratamiento de la infección respiratoria grave por SARS-CoV-2

    Reumatologia clinica, Vol. 19, Núm. 2, pp. 121

2022

  1. Acquired haemophilia A secondary to metastatic prostate cancer

    Medicina Clinica

  2. Autoimmune Haemolytic Anaemia Due to Cold Antibodies in a Renal Cancer Patient

    Case Reports in Oncology, Vol. 15, Núm. 2, pp. 507-514

  3. Cancer and elderly: Two incompatible concepts for intensive care?

    Revista Espanola de Geriatria y Gerontologia

  4. Immunohistochemical Assessment of the P53 Protein as a Predictor of Non-Small Cell Lung Cancer Response to Immunotherapy

    Frontiers in bioscience (Landmark edition), Vol. 27, Núm. 3, pp. 88

  5. Influence of DNA Mismatch Repair (MMR) System in Survival and Response to Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC): Retrospective Analysis

    Biomedicines, Vol. 10, Núm. 2